Robert Lauzon Diplomat Pharmacy Inc DPLO-N PAST TOP PICK May 23, 2019

(A Top Pick May 03/18, Down 75%) They did a major acquisition that did not work out. He bought it thinking management could execute better. He thinks AMZN-Q could start to kick their tires.

Robert Lauzon

Owned

Unlock Rating

$5.110

Stock price when the opinion was issued

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

They are the largest publicly traded pharma company. If you have a specialty drug that has to be delivered to the home and then infused, this is the company to do it. This is who AMZN-Q would have to take out in order to do it. (Analysts’ target: $26.10).

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Robert Lauzon Diplomat Pharmacy Inc DPLO-N PAST TOP PICK May 23, 2019

You might be interested:

Diplomat Pharmacy Inc(DPLO-N)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Chris Blumas

Eric Nuttall

The Panic-Proof Portfolio (Stockchase Research)

David Burrows

Larry Berman CFA, CMT, CTA